<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Tricyclics and malignant syndrome

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1996Publisher:Cambridge University Press (CUP)Journal:European Psychiatry, volume 11, pages 212-213 (issn: 0924-9338, eissn: 1778-3585,

Authors: B Carlander; M Abbar; D Castelnau;

doi: 10.1016/0924-9338(96)88395-7

pmid: 19698454

Tricyclics and malignant syndrome

- Summary
- Metrics

Abstract

SummaryA clinical and biological pattern similar to that of neuroleptic malignant syndrome is reported in a depressed patient treated with trimipramine, without any concomitant use of neuroleptics. The antidopaminergic properties of this drug, one of the tricyclic antidepressants, may account for this uncommon side effect.

Related Organizations

University Hospital of Montpellier
France
Hôpital Lapeyronie
France

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	4
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average